PT - JOURNAL ARTICLE AU - Gourishankar, Anand AU - Akkinapally, Smita. S. TI - Urinary tract infection in infants with asymptomatic Jaundice: a meta-analysis UTI and Jaundice Review AID - 10.1101/2022.07.26.22278041 DP - 2022 Jan 01 TA - medRxiv PG - 2022.07.26.22278041 4099 - http://medrxiv.org/content/early/2022/07/29/2022.07.26.22278041.short 4100 - http://medrxiv.org/content/early/2022/07/29/2022.07.26.22278041.full AB - INTRODUCTION Infants, especially neonates, present with jaundice with an unclear association with urinary tract infection. Evidence for such association is unclear, especially in a specific group of otherwise well-appearing infants born > 35 weeks.Data sources We used the following databases: Medline, Embase, CINAHL Plus, Scopus, and Cochrane library.Study selection We included observational studies that included infants born > 35 weeks gestation, younger than 12 months, asymptomatic other than jaundice, and urinary tract infection. Data extraction: After reviewing the eligibility, two reviewers extracted data and assessed the quality of each study using the Newcastle-Ottawa scale.EVIDENCE SYNTHESIS We analyzed sixteen studies for a total of 2933 infants. The pooled incidence of UTI was 9.6% (95% confidence interval of 6% to 15%). The subgroup analysis failed to show any difference in incidence within the publication year, sample size, study design, study region, urine collection method, and age group. There was no explanation of heterogeneity noted by the meta-regression for UTI incidence with publication year, total bilirubin, sample size, and study quality. The funnel plot and Egger’s test revealed publication bias.CONCLUSIONS Nearly 1 in 10 otherwise asymptomatic infants with jaundice have a UTI. We recommend a rigorous large prospective study to confirm this finding.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors.